Characterization of the IVS-II-821 (A>C) (HBB: c.316-30A>C) Mutation in a β-Thalassemia Phenotype in Iran

References

• Cai S, Eng B, Francombe W, et al. Two novel β-thalassemia mutations in the 5′ and 3′ noncoding regions of the β-globin gene [see comments]. Blood. 1992;79(5):1342–1346.
   PubMed Web of Science ®Google Scholar
• Guvenc B, Canataroglu A, Unsal C, et al. β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study. Arch Med Sci. 2012;8(3):411–414.
   PubMed Web of Science ®Google Scholar
• Kulkarni GD, Kulkarni SS, Kadakol GS, et al. Molecular basis of β-thalassemia in Karnataka, India. Genet Test Mol Biomarkers. 2012;16(2):138–141.
   PubMed Web of Science ®Google Scholar
• Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol/Oncol. 2007;29(4):233–238.
   PubMed Web of Science ®Google Scholar
• Old J, Harteveld CL, Traeger-Synodinos J, et al. Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 2: Laboratory Protocols [Internet], 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2012.
   Google Scholar
• Rudra T, Chakrabarti S, Sengupta B. α-Thalassaemia: experience of referral cases in Kolkata, India. Int J Hum Genet. 2008;8(4):357–360.
   Web of Science ®Google Scholar
• Orkin SH, Antonarakis SE, Kazazian HH Jr. Polymorphism and molecular pathology of the human β-globin gene. Prog Hematol. 1983;13:49–73.
   PubMedGoogle Scholar
• Thein SL. Genetic modifiers of β-thalassemia. Haematologica. 2005;90(5):649–660.
   PubMed Web of Science ®Google Scholar
• Giardine B, van Baal S, Kaimakis P, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28(2):206 (http://globin.cse.psu.edu).
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Raygani AV, Merat A, et al. Thalassemic mutations in southern Iran. Iranian J Med Sci. 2015;31(2)70–73.
   Google Scholar
• Huisman THJ, Carver MFH. The β-and-Thalassemia Repository (Part I). Hemoglobin. 1998;22(2):169–195.
   PubMed Web of Science ®Google Scholar
• Patrinos GP, Kollia P, Papadakis MN. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies. Hum Mutat. 2005;26(5):399–412.
   PubMed Web of Science ®Google Scholar
• Bilgen T, Clark O, Ozturk Z, et al. Two novel mutations in the 3′ untranslated region of the β globin gene that are associated with the mild phenotype of β thalassemia. Int J Lab Hematol. 2013;35(1):26–30.
   PubMed Web of Science ®Google Scholar
• Mehrabi M, Alibakhshi R, Fathollahi S, Farshchi MR. The spectrum of β-thalassemia mutations in Kermanshah Province in West Iran and its association with hematological parameters. Hemoglobin. 2013;37(6):544–552.
   PubMed Web of Science ®Google Scholar
• Azimi A, Alibakhshi R, Hayati H, et al. IVS-II-648/649 (–T) (HBB: c.316-202del) triggers a novel β-thalassemia phenotype. Hemoglobin. 2017;41(1):44–46.
   PubMed Web of Science ®Google Scholar
• Shahbazi M, Pravica V, Nasreen N, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet. 2002;359(9304):397–401.
   PubMed Web of Science ®Google Scholar
• Cartegni L, Wang J, Zhu Z, et al. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31(13):3568–3571.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li W-H, Krainer AR, Zhang MQ. RNA landscape of evolution for optimal exon and intron discrimination. Proc Natl Acad Sci USA. 2008;105(15):5797–5802.
   PubMed Web of Science ®Google Scholar
• Goren A, Ram O, Amit M, et al. Comparative analysis identifies exonic splicing regulatory sequences – the complex definition of enhancers and silencers. Mol Cell. 2006;22(6):769–781.
   PubMed Web of Science ®Google Scholar
• Kazazian HH Jr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol. 1990;27(3):209–228.
   PubMed Web of Science ®Google Scholar
• Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3(4):285–298.
   PubMed Web of Science ®Google Scholar
• Hijikata A, Raju R, Keerthikumar S, et al. Mutation@A Glance: an integrative web application for analysing mutations from human genetic diseases. DNA Res. 2010;17(3):197–208.
   PubMed Web of Science ®Google Scholar
• Liu H-X, Chew SL, Cartegni L, et al. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol Cell Biol. 2000;20(3):1063–1071.
   PubMed Web of Science ®Google Scholar
• Liu H-X, Zhang M, Krainer AR. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 1998;12(13):1998–2012.
   PubMed Web of Science ®Google Scholar
• Wang Z, Rolish ME, Yeo G, et al. Systematic identification and analysis of exonic splicing silencers. Cell. 2004;119(6):831–845.
   PubMed Web of Science ®Google Scholar
• Homolova K, Zavadakova P, Doktor TK, et al. The deep intronic c.903 + 469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria. Hum Mutat. 2010;31(4):437–444.
   PubMed Web of Science ®Google Scholar
• Trabelsi M, Beugnet C, Deburgrave N, et al. When a mid-intronic variation of DMD gene creates an ESE site. Neuromusc Disord. 2014;24(12):1111–1117.
   PubMed Web of Science ®Google Scholar
• Hastings ML, Krainer AR. Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol. 2001;13(3):302–309.
   PubMed Web of Science ®Google Scholar
• Zatkova A, Messiaen L, Vandenbroucke I, et al. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum Mutat. 2004;24(6):491–501.
   PubMed Web of Science ®Google Scholar
• HbVar database [Internet]. (http://globin.bx.psu.edu/hbvar/menu.html) Accessed on September 28 2018.
   Google Scholar
• Alanazi M, Abduljaleel Z, Khan W, et al. In silico analysis of single nucleotide polymorphism (SNPs) in human β-globin gene. PloS One. 2011;6(10):e25876.
   PubMed Web of Science ®Google Scholar
• Carlice-dos-Reis T, Viana J, Moreira FC, et al. Investigation of mutations in the HBB gene using the 1,000 genomes database. PloS One. 2017;12(4):e0174637.
   PubMed Web of Science ®Google Scholar
• Giambona A, Passarello C, Cassarà F, et al. Phenotypic evaluations of –223T>C (HBB: c.-223T>C) nucleotide substitution in the promoter region of β-globin gene. Blood Cells Mol Dis. 2015;55(3):218–219.
   PubMed Web of Science ®Google Scholar
• Mahdieh N, Rabbani B. β Thalassemia in 31,734 cases with HBB gene mutations: pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East. Blood Rev. 2016;30(6):493–508.
   PubMed Web of Science ®Google Scholar